🔓
Sign in as a Member to unlock the full view of TEVA. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$24.50/mo already a Member? Sign in →
TEVA

Teva Pharmaceutical Industries Limited

Sector: healthcareDrug Manufacturers - Specialty & GenericNYSEMarket Cap: $39.24B

Teva Pharmaceutical Industries Limited is a global generic and specialty pharmaceutical company with significant political exposure through $13.8M in annual doctor payments (2024) but no federal contracts, lobbying, or insider buys.

Govt Dependence
10/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat TEVA does

Teva develops, manufactures, and markets generic and specialty medicines globally, with revenue lines including generic pharmaceuticals, specialty medicines (CNS, respiratory), and active pharmaceutical ingredients (APIs). The company operates in North America, Europe, and international markets.

12 months past · 3 months futureTEVA activity timeline

$37$26$15 AugSepOctNovDecJan '26FebMarAprMayJunJulAugSepOct ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Jul 29 $36.34 hi $15.38 lo $30.81 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 28 Two Sigma Investments · + $11048M · 2026-03-31Citadel Advisors · + $115M · 2025-12-31Coatue Management · - $67M · 2025-12-31Viking Global Investors · - $51M · 2025-09-30Coatue Management · + $47M · 2025-09-30Citadel Advisors · - $44M · 2025-09-30Bridgewater Associates · - $24M · 2025-12-31 S.827 · markup · 2025-07-30HR.2001 · committee · 2026-07-21HR.1860 · committee · 2025-09-16 MARKUP · Senate Health, Education, Labor, and Pensions Subcommittee o · 2026-07-29MARKUP · Senate Health, Education, Labor, and Pensions · 2026-07-30MARKUP · Senate Budget · 2026-08-04
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) carveout (this ticker)
248 trading days · 0 congressional trades shown · 0 insider buys · 7 13F filings · 3 past bill actions · 3 upcoming markups

Lifetime Government AwardsTEVA federal contracts

TEVA doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding TEVA

$11.27B
Total TEVA held by tracked 13F funds
5
Funds with TEVA positions
Two Sigma Investments $11.05B +61% 2026-03-31
Citadel Advisors $115M +70% 2025-12-31
Coatue Management $67M -8% 2025-12-31
Bridgewater Associates $24M -13% 2025-12-31
D.E. Shaw & Co. $20M +283% 2025-12-31

Congressional TradesWho in Congress is trading TEVA

2020-11-13 (unknown) Purchase $15,001 - $50,000
2020-11-13 (unknown) purchase $15,001 - $50,000
2020-05-07 (unknown) Sale $1,001 - $15,000
2020-05-07 (unknown) sale $1,001 - $15,000
2019-06-19 (unknown) sale $1,001 - $15,000
2019-06-19 (unknown) Sale $1,001 - $15,000
2018-02-12 (unknown) purchase $15,001 - $50,000 49d late
2018-02-12 (unknown) Purchase $15,001 - $50,000 49d late
2017-05-30 (unknown) sale $1,001 - $15,000 48d late
2017-05-30 (unknown) Sale (Full) $1,001 - $15,000 48d late
2017-06-15 Patty Murray D-Washington · senate Sale (Full) $1,001 - $15,000
2017-06-15 Patty Murray D-Washington · senate sale $1,001 - $15,000
30+ trades on file · most recent 2020-12-02

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Bills Affecting TEVALive legislation impacting this stock

Political ProfileWhere TEVA sits in Washington

[object Object]

STRUCTURAL: High regulatory density (85) due to healthcare sector and doctor payment exposure ($13.8M in 2024). EVIDENTIARY: No federal contracts, lobbying, insider buys (tier F, 0 buys), or congressional trades. Net: Regulatory overhead without direct political engagement.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Increased scrutiny of doctor payments under transparency laws
    HHS/CMS
    "get_political_influence.doctor_payments shows $13.8M in 2024 payments to doctors by Teva Pharmaceuticals USA, Inc."

Regulatory opportunities

  • Potential generic drug legislation easing market entry
    FDA
    "Recent bill_impacts include multiple healthcare bills with low impact_ratios (0.0001-0.0002), indicating minor regulatory sensitivity"
Member intelligence layer

Live signals + predictions for TEVA — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout TEVA & political exposure

Does Teva Pharmaceutical Industries Limited (TEVA) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Teva Pharmaceutical Industries Limited. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded TEVA stock?
52 congressional trades by 11 unique members of Congress, most recently on 2020-11-13. See the Congressional Trading panel for politician-by-politician breakdown.
What is TEVA political risk profile?
Government dependence: 10/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track TEVA political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. TEVA data is updated daily from these official federal sources.